Although BDNF/TrkB signaling is involved in tumorigenicity and malignant progression to invasiveness in large cell neuroendocrine carcinoma (LCNEC) and may be a potential target in LCNEC26, 27, how this signaling is activated is not well understood. Here, NTRK2 is linked to large cell neuroendocrine carcinoma.